STOCK TITAN

Immuron (NASDAQ: IMRN) details ASX unquoted securities notice in 6-K

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Immuron Limited filed a Form 6-K as a foreign private issuer for August 2025 to furnish two announcements previously published on the Australian Securities Exchange. These ASX notices, titled Appendix 3G, are attached, including Exhibit 99.2, a notification regarding unquoted securities for IMC.

Positive

  • None.

Negative

  • None.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of August 2025

 

Commission File Number: 001-38104

 

IMMURON LIMITED

(Name of Registrant)

 

Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes ☐       No ☒

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

  

 

 

 

 

  

IMMURON LIMITED

 

EXPLANATORY NOTE

 

Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on August 15, 2025 titled:

 

      - Appendix 3G
      -  

 

A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

 

This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

 

1

 

 

EXHIBITS

 

Exhibit
Number
  Description
99.2   Notification regarding unquoted securities - IMC 

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  IMMURON LIMITED
     
Date: August 15, 2025 By:  /s/ Phillip Hains
    Phillip Hains
    Company Secretary

 

 

 

3

FAQ

What does Immuron Limited's (IMRN) August 2025 Form 6-K cover?

The August 2025 Form 6-K from Immuron Limited furnishes two Australian Securities Exchange announcements titled Appendix 3G. It also includes an exhibit labeled 99.2, which is a notification regarding unquoted securities for IMC made available to U.S. investors via this report.

Why did Immuron Limited (IMRN) submit this Form 6-K?

Immuron submitted this Form 6-K to furnish to U.S. markets the same Appendix 3G announcements it released on the Australian Securities Exchange. The report formally transmits these public notices and their exhibit, ensuring consistent disclosure between Australian and U.S. investors.

What is Exhibit 99.2 in Immuron Limited's Form 6-K?

Exhibit 99.2 is titled “Notification regarding unquoted securities - IMC.” It is attached to Immuron Limited’s Form 6-K as part of the ASX Appendix 3G announcements, providing additional detail about unquoted securities associated with the IMC designation for market participants.

Are the materials in Immuron Limited's Form 6-K considered filed under the Exchange Act?

The materials in this Form 6-K, including its exhibit, are expressly stated as not deemed “filed” for purposes of the Exchange Act. They are also not automatically incorporated into any Securities Act filings unless specifically referenced in another filing.

Who signed Immuron Limited's August 2025 Form 6-K?

The Form 6-K was signed on behalf of Immuron Limited by Phillip Hains, the Company Secretary. His signature confirms authorization for the company’s August 15, 2025 submission, including the attached Australian Securities Exchange notices and Exhibit 99.2 relating to unquoted securities.

Does Immuron Limited use Form 20-F or Form 40-F for annual reports?

The Form 6-K indicates that Immuron Limited uses the Form 20-F framework for its annual reports as a foreign private issuer. This aligns its primary annual disclosure format with the standard typically used by non-North American foreign companies listed in the United States.
Immuron Ltd

NASDAQ:IMRN

View IMRN Stock Overview

IMRN Rankings

IMRN Latest News

IMRN Latest SEC Filings

IMRN Stock Data

6.61M
8.17M
Biotechnology
Healthcare
Link
Australia
Carlton